Topics New Scientific Outputs related to COVID-19
New Scientific Outputs related to COVID-19
Here in “New Scientific Outputs” we are introducing the outlines of preliminary reports on preprint servers which are related to COVID-19 and supported by AMED. These reports have undergone AMED’s internal review.The areas of our focus on this website are molecular epidemiology, pathogenesis, diagnostics, drug development, and vaccine development. The preprint servers of interest are: bioRxiv, medRxiv, chemRxiv.
Caution: Papers on preprint servers are preliminary reports that have not been peer-reviewed. These reports will be deleted from this website when they are accepted in a peer reviewed journal or a certain period of time has passed.
|5||Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3||Kazuto Yoshimi, et al.||Posted Date: 2020/6/2|
|4||SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation varian||Yoriyuki Konno, et al.||Posted Date: 2020/5/11|
|3||Multidrug treatment with nelfinavir and cepharanthine against COVID-19||Hirofumi Ohashi, et al.||Posted Date:2020/04/14|
|2||Knowledge-based structural models of SARS-CoV-2 proteins and their complex with potential drugs||Atsushi Hijikata, et al.||Posted Date:2020/03/24|
|1||Identification of Key Interactions Between SARS-CoV-2 Main Protease and Inhibitor Drug Candidates||Ryunosuke Yoshino, et al.||Posted Date:2020/03/23|
Last updated 2020.6.24